Proliferation News and Research

RSS

Unlocking the potential of melatonin: A promising epigenetic weapon against cancer

Melatonin, a hormone derived from the pineal gland, has diverse effects on cellular processes. This review explores its potential role as an epigenetic regulator, particularly in modulating DNA methylation, and suggests its use in combination therapy as a novel anticancer strategy.

30 May 2023

Study identifies a novel druggable signaling molecule involved in obesity and diabetes

More than 40% of Americans are considered obese, and the trend continues to grow. The treatments or preventive options for obesity and obesity-associated diseases are limited.

26 May 2023

Researchers explore the possibility of treating lung cancer by targeting telomeres

Healthy cells can only divide a limited number of times during an organism's lifetime. In contrast, tumor cells are immortal: they proliferate indefinitely and uncontrollably, and this is the defining characteristic of cancer.

26 May 2023

Looking at cancer drugs to help put the brakes on classic indicators of aging

Antiretroviral cocktails can make human immunodeficiency virus, or HIV, undetectable and untransmittable, but both the virus and its treatment can also accelerate aging of bone and muscle.

24 May 2023

GPR141 drives breast tumorigenesis by inducing tumor cell properties via the p-mTOR1/p53 axis

A new research paper was published in Oncotarget's Volume 14 on May 19, 2023, entitled, "G-protein-coupled receptor 141 mediates breast cancer proliferation and metastasis by regulating oncogenic mediators and the p-mTOR/p53 axis."

23 May 2023

Metabolic sensors may play a role in the development of Alzheimer's disease, study suggests

It's well-known that people with Type 2 diabetes are at an increased risk of developing Alzheimer's disease, but the reason why isn't fully understood and is an area of current research.

22 May 2023

Researchers receive $2.3 million to continue development of a new ‘glyco-immune’ checkpoint inhibitor

Researchers from Rice University and Baylor College of Medicine are hoping a first-of-its-kind "glyco-immune" checkpoint inhibitor could be the key to stopping bone cancer metastasis for breast cancer survivors.

19 May 2023

Identify the underlying mechanism associated with the initiation of focal amplification in breast cancer

Identifying the underlying mechanism associated with the initiation of focal amplification in breast cancer.

19 May 2023

Unlocking the gut clock: How circadian rhythms and gut microbiota team up to impact human health

Research investigates the connection between circadian rhythms and specific microbial patterns in various disease contexts, emphasizing the need for further studies.

15 May 2023

Phase 1 clinical trial of CAR-NKT cell therapy shows promising results in neuroblastoma patients

Researchers at Baylor College of Medicine/Texas Children's Cancer Center and collaborating institutions report interim results from a first-in-human phase 1 clinical trial evaluating the safety, antitumor activity and immunological characteristics of a genetically engineered natural killer T (NKT) cell immunotherapy for neuroblastoma, a childhood tumor that most commonly arises in the adrenal gland.

15 May 2023

Supercharge your health with carotenoids

This review highlights carotenoids' various biological activities, including antioxidant, anti-tumor, anti-diabetic, anti-aging, and anti-inflammatory effects, with a specific focus on lycopene.

15 May 2023

Fatty liver promotes the spread of colorectal cancer to the liver

Investigators at Cedars-Sinai Cancer found that fatty liver, a condition closely associated with obesity, promotes the spread of colorectal cancer to the liver.

11 May 2023

Research sheds light on the early cellular events that give rise to pancreatic cancer

Discussions of cancer often stress the genetic mutations that drive disease by altering the normal function of cellular proteins.

11 May 2023

What are the potential consequences of unchecked AI proliferation?

Research paper discusses the potential threats posed by artificial intelligence (AI) to human health and well-being, including control and manipulation of people, dehumanizing lethal weapon capacity, and rendering human labor obsolete. It also highlights the need for effective regulation and calls for a moratorium on the development of self-improving AI.

11 May 2023

Proliferation News and Research

Unlocking the potential of melatonin: A promising epigenetic weapon against cancer

Study identifies a novel druggable signaling molecule involved in obesity and diabetes

Researchers explore the possibility of treating lung cancer by targeting telomeres

Looking at cancer drugs to help put the brakes on classic indicators of aging

GPR141 drives breast tumorigenesis by inducing tumor cell properties via the p-mTOR1/p53 axis

Metabolic sensors may play a role in the development of Alzheimer's disease, study suggests

Researchers receive $2.3 million to continue development of a new ‘glyco-immune’ checkpoint inhibitor

Identify the underlying mechanism associated with the initiation of focal amplification in breast cancer

Unlocking the gut clock: How circadian rhythms and gut microbiota team up to impact human health

Phase 1 clinical trial of CAR-NKT cell therapy shows promising results in neuroblastoma patients

Supercharge your health with carotenoids

Fatty liver promotes the spread of colorectal cancer to the liver

Research sheds light on the early cellular events that give rise to pancreatic cancer

What are the potential consequences of unchecked AI proliferation?

Protein inhibition could offer new strategies for treating severe asthma

Is wind spreading urban malaria?

High-grade gliomas remodel neural circuits: promoting tumor progression and impaired cognition

Finnish mitochondrial disease of newborns shows cancer-like changes in proliferating cells

Drugs targeting FXR1 may treat vascular proliferative diseases

Study evaluates the effects of phenolic compounds in extra virgin olive oil on skin health

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News